b.demir

TL2 · Łódź

Contributes reviews on supplier material. Based in Łódź.

Joined 7 June 2025 · last posted 4d

80 posts, newest first. Showing up to 150.

Distinguishing a red flag from an inconvenience — a second dataset Replied, post #10 · Sourcing › Red flags · 24 Jul 2026 · 13 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
Seven-day rolling means and why weekly readings mislead Replied, post #91 · Outcomes › Progress reports · 23 Jul 2026 · 13 likes Post #90 is right about the mechanism and I think understates the practical bit. Two questions I would want answered before drawing anything from the seven-day rolling…
Search filters: what is missing Replied, post #83 · Meta › Site feedback · 20 Jul 2026 · 20 likes Worth separating two things that post #81 runs together. Two people in this thread mean different things by search filters and are disagreeing about the definition…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #88 · Analytics › Home & field testing · 15 Jul 2026 · 14 likes Adding a data point of agreement rather than a data point.
GLP-1 receptor distribution: central and peripheral Replied, post #89 · Pharmacology › Receptor biology · 13 Jul 2026 · 3 likes The area postrema sits outside the blood-brain barrier and is where a great deal of the nausea signalling in this class originates. That is why the effect is central…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #17 · Practice › Interactions · 12 Jul 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #63 · Analytics › Home & field testing · 7 Jul 2026 · 0 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #13 · Analytics › Mass spectrometry · 26 Jun 2026 · 5 likes Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a million. On a high-resolution instrument a low single-digit figure is…
How to ask a question when you cannot say why you are asking it Replied, post #21 · Start Here › How to Ask · 24 Jun 2026 · 11 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
About the Mass spectrometry category Replied, post #4 · Analytics › Mass spectrometry · 20 Jun 2026 · 10 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #79 · Devices › Syringes & needles · 20 Jun 2026 · 9 likes Post #77 is right about the mechanism and I think understates the practical bit. Sharps containers are a legal requirement for disposal in several jurisdictions and a…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #9 · Compounds › Retatrutide · 19 Jun 2026 · 28 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #93 · Sourcing › Logistics · 6 Jun 2026 · 30 likes Counterpoint on Regional warehouse stock versus direct, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #70 · Sourcing › Red flags · 5 Jun 2026 · 0 likes Confirming post #69 from a second method, which matters more than confirming it from a second person. Adding what did not work for me on certificate whose chromatogram…
Reading a trial's population section before its results Replied, post #59 · Evidence › Trials · 27 May 2026 · 0 likes Reading the supplementary appendix is where most of the real information is, and it is where almost nobody goes. The baseline table alone answers half the…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #28 · Practice › Storage & stability · 15 May 2026 · 20 likes I read post #24 twice before replying, because I had assumed the opposite. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #119 · Compounds › Tirzepatide · 11 May 2026 · 0 likes Where I part company with post #117, and it is a narrow parting. SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #75 · Start Here › Welcome · 6 May 2026 · 13 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Why the timeline is on the right and not the left — what changed since Replied, post #27 · Meta › Site feedback · 28 Apr 2026 · 20 likes Post #26 describes the usual case. This is about the unusual one. Display issues: broken layouts, images not loading, text overlapping — report with the browser and…
List price versus negotiated price versus what you pay Replied, post #89 · Access › Pricing · 15 Apr 2026 · 10 likes Adding a data point of agreement rather than a data point.
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #60 · Analytics › Method validation · 30 Mar 2026 · 0 likes Post #59 is right about the mechanism and I think understates the practical bit. The thing about Robustness that took me longest to accept is that a plausible mechanism…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #24 · Lounge › Introductions · 9 Mar 2026 · 5 likes Welcome. Nobody will mind you asking something basic. The people most likely to answer are the ones who remember not knowing it. I would want the raw data before…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #56 · Outcomes › Progress reports · 14 Feb 2026 · 5 likes State the method before the numbers. Same scale, same time of day, same conditions — without that a series is a collection of readings rather than a measurement. I have…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #83 · Wellbeing › Mental health · 28 Jan 2026 · 5 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
Waist circumference technique and its repeatability Replied, post #41 · Outcomes › Progress reports · 21 Jan 2026 · 0 likes Circumference measurements at marked sites are cheap, reproducible within a person, and more informative than they get credit for.
The most common factual error about semaglutide on the internet — what changed since Replied, post #4 · Compounds › Semaglutide · 8 Jan 2026 · 24 likes Post #2 is right about the mechanism and I think understates the practical bit. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly…
Tracking that stops updating and then resumes Replied, post #60 · Sourcing › Logistics · 25 Dec 2025 · 27 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. On reflection I would soften that…
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Started this topic · Data & Tools › Datasets · 11 Dec 2025 · 2 likes Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? I have a specific reason for asking rather than idle curiosity, and the…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #17 · Compounds › Retatrutide · 4 Dec 2025 · 4 likes Picking up post #16: that is the part I would want checked first. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #27 · Data & Tools › Calculators · 4 Dec 2025 · 19 likes Dose-equivalence calculators between compounds should be treated with real suspicion, because equivalence between these compounds has not been established in the way…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #47 · Sourcing › Regulatory · 24 Nov 2025 · 0 likes Post-authorisation safety commitments are public and are one of the more useful sources for what a regulator considered uncertain at approval. The number is defensible.…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #5 · Practice › Side effects · 21 Nov 2025 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Request: export my own posts — one year on Replied, post #13 · Meta › Feature requests · 17 Nov 2025 · 9 likes Post #12 is right about the mechanism and I think understates the practical bit. Duplicate requests: if several people request the same feature, the requests often get…
The anatomy of a question that gets answered within an hour — the long version Replied, post #4 · Start Here › How to Ask · 17 Oct 2025 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
When to stop reading forums, including this one Replied, post #37 · Wellbeing › Mental health · 16 Oct 2025 · 6 likes Adding the measurement that post #36 says would settle it. Expectations set by other people's reported trajectories are a documented source of distress, and the…
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 8 Oct 2025 · 2 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
A parcel that arrived warm: a decision process, not a verdict Replied, post #51 · Practice › Storage & stability · 23 Sep 2025 · 0 likes Adding the measurement that post #50 says would settle it. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
Can a home kit substitute for a laboratory report? A careful no Replied, post #15 · Analytics › Home & field testing · 20 Sep 2025 · 0 likes No notes. Posting so the count is not one.
Why catalogue breadth is not evidence of anything — what changed since Replied, post #39 · Compounds › Other compounds · 8 Sep 2025 · 5 likes On post #37 — agreed on the reasoning, with one qualification. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #51 · Data & Tools › Datasets · 8 Sep 2025 · 1 like Something worth flagging about Aggregated purity results across four: the strongest-sounding claims in this thread are the ones with no source attached, which is the…
Confounding by indication, explained with a concrete example Replied, post #3 · Evidence › Study critique · 30 Aug 2025 · 6 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. The pre-specified endpoint being a weaker proxy than you would like is a…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #13 · Sourcing › Regulatory · 29 Aug 2025 · 30 likes Post #10 answers the question as asked. The question underneath it is different. Import restrictions vary by compound and by jurisdiction: what is a controlled…
Comparing my trajectory with the trial curves, carefully Replied, post #40 · Outcomes › Progress reports · 25 Aug 2025 · 0 likes Post #39 is the version of this I will quote in future. One addition. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #39 · Evidence › Journal club · 22 Aug 2025 · 8 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. It is worth…
How to research a compound with no human data without deceiving yourself Replied, post #59 · Compounds › Other compounds · 2 Aug 2025 · 16 likes PT-141 was developed from the same family with a different receptor profile, and it has a considerably better documented human evidence base than most compounds…
Asking about a compound your prescriber has not heard of Replied, post #112 · Clinical › Prescriber conversations · 1 Aug 2025 · 22 likes Post #110 is the version of this I will quote in future. One addition. Asking what monitoring is planned and why makes the monitoring make sense, and makes it likelier…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #75 · Compounds › Cagrilintide & amylin analogues · 28 Jul 2025 · 0 likes Post #71 put the caveat in the right place and I want to underline it. Marking my uncertainty on cagrisema phase 2 paper explicitly. I am confident about the direction,…
Coming back to: What published stability data actually covers, and what it does not Replied, post #84 · Practice › Storage & stability · 11 Jul 2025 · 28 likes The arithmetic in post #82 is right; the assumption feeding it is the part to check. Where I would push back on the published stability data actually covers consensus…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #61 · Evidence › Journal club · 30 Jun 2025 · 0 likes Confirming post #59 from a second method, which matters more than confirming it from a second person. I would call the community position on SURMOUNT-4 and continuation…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 8 Jun 2025 · 21 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
A well-designed study with a badly written abstract Replied, post #129 · Evidence › Study critique · 4 Jun 2025 · 20 likes On post #127 — agreed on the reasoning, with one qualification. I would call the community position on well-designed study likely rather than established, and I would…
Half-life, steady state, and accumulation worked through Replied, post #36 · Pharmacology › Pharmacokinetics · 29 May 2025 · 3 likes The arithmetic on half-life is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Follow-up: Documentation that appears only after payment Replied, post #75 · Sourcing › Red flags · 14 May 2025 · 6 likes Answering the question post #71 raises rather than the one it answers. For anyone finding this later: the short answer on Documentation is that it depends on one thing,…
Cost per milligram, computed honestly across formats — the long version Replied, post #92 · Access › Pricing · 8 May 2025 · 13 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion. Reporting the observation and leaving the explanation open…
Carryover and the ghost peak from last week's standard Replied, post #64 · Analytics › HPLC & UHPLC · 9 Apr 2025 · 14 likes On post #62 — agreed on the reasoning, with one qualification. Injection volume matters because column overload distorts peak shape, and an overloaded main peak can…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #101 · Access › International · 15 Mar 2025 · 14 likes Cross-border purchase within is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
Maintainer handover: how it works Replied, post #33 · Meta › Wiki maintenance · 15 Mar 2025 · 5 likes Same experience here, different supplier, so it is at least not unique to one of them.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #36 · Compounds › Semaglutide · 11 Mar 2025 · 1 like Picking up post #33: that is the part I would want checked first. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with…
Checking someone else's arithmetic: a worked example thread Replied, post #27 · Practice › Reconstitution · 6 Mar 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That is one…
When to suspect the method rather than the sample Replied, post #88 · Analytics › Method validation · 26 Feb 2025 · 16 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
Protein density versus volume when you cannot eat much Replied, post #26 · Nutrition & Training › Protein & intake · 27 Jan 2025 · 0 likes Answering the question post #23 raises rather than the one it answers. Protein supplements: whey, casein, and plant-based protein powders can help hit targets when…
Reading an MS report that only gives you a single number Started this topic · Analytics › Mass spectrometry · 24 Jan 2025 · 7 likes On the subject in the title: Reading an MS report that only gives you a single number Working notes rather than a conclusion. I would like to understand what this…
The topic list is dense — is that deliberate? Replied, post #86 · Meta › Site feedback · 21 Jan 2025 · 15 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #3 · Compounds › Tirzepatide · 12 Jan 2025 · 16 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #3 · Compounds › Retatrutide · 4 Jan 2025 · 0 likes Picking up the opening post: that is the part I would want checked first. Retatrutide is investigational. Anything obtained outside a trial is by definition…
Holding a dose indefinitely: is there a documented downside? Replied, post #5 · Practice › Dosing & titration · 30 Dec 2024 · 0 likes Narrowing post #4, because the general version has more than one answer. Dose equivalence between different incretin analogues is a weak concept. The molecules differ…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #94 · Access › Insurance & coverage · 29 Dec 2024 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Coming back to: When to suspect the method rather than the sample Replied, post #127 · Analytics › Method validation · 24 Dec 2024 · 18 likes Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it.
Building a sensible monitoring schedule with your prescriber Replied, post #93 · Clinical › Bloodwork · 22 Dec 2024 · 9 likes The arithmetic in post #92 is right; the assumption feeding it is the part to check. A trend needs at least three points to be a trend. Two points are a line and a line…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 11 Dec 2024 · 5 likes The honest summary of the evidence base: a coherent mechanism, good phase 2 data in combination, and much less standalone human data than the volume of discussion…
Journal club: SURMOUNT-1, read without the press release Replied, post #20 · Evidence › Journal club · 28 Nov 2024 · 1 like SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #8 · Compounds › Secretagogues & GH axis · 22 Nov 2024 · 0 likes Narrowing post #5, because the general version has more than one answer. Reframing GHRH analogues versus ghrelin mimetics slightly, because I think the disagreement is…
EMA product information as a primary source — does this still hold? Replied, post #11 · Regional › European Union · 14 Nov 2024 · 0 likes Parallel distribution is a real mechanism and produces packaging that looks unfamiliar for legitimate reasons. The answer changed when I changed how I was measuring,…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #32 · Clinical › Prescriber conversations · 5 Nov 2024 · 14 likes Building on post #30 rather than restating it. Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final…
Time to steady state after a dose increase Replied, post #17 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 0 likes Everything in post #15 holds. The case it does not cover is the one I have. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #5 · Wellbeing › Mental health · 25 Sep 2024 · 16 likes This settles it for me, at least until somebody posts a reason it should not.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #35 · Analytics › Method validation · 18 Sep 2024 · 5 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways. It is worth stating the boring…
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #24 · Clinical › Special populations · 9 Sep 2024 · 0 likes Adding the measurement that post #21 says would settle it. Almost every population discussed here was excluded from the pivotal trials, which means the evidence base is…
Blind submission and why it changes minds Replied, post #25 · Sourcing › Independent verification · 30 Jul 2024 · 23 likes A note on scope: what I am saying about blind submission applies to the case in the first post and I would not extend it further without checking.
The mass-error checker and its intended scope Replied, post #19 · Data & Tools › Calculators · 30 May 2024 · 28 likes Post #18 is the version of this I will quote in future. One addition. A request rather than an answer: could whoever has the primary source for mass-error checker post…